Actively Recruiting
Endoscopic Retrograde Cholangiopancreatography Patient Registry Observational Study at Methodist Dallas Medical Center
Led by Methodist Health System · Updated on 2026-03-24
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to collect and store detailed information about patients who undergo Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures at Methodist Dallas Medical Center. The study focuses on factors influencing the risk of pancreatitis following ERCP, a serious complication, and supports quality improvement and research efforts related to gastro-intestinal disorders. Patients included in this registry are those who had ERCP performed at the center between January 1, 2000, and December 31, 2025. The study gathers data permissively for up to 25 years to monitor patient outcomes and procedural details. No specific treatments or interventions are assigned; instead, data from past and future ERCP cases are collected for observational purposes. Participants' information, including procedural records and outcomes, will be stored and analyzed to understand risks and improve care. The primary measure is the inclusion of patients who underwent ERCP over the 25-year period. The study does not involve additional interventions or treatment changes and will continue data collection until the end date in February 2028.
CONDITIONS
Brief Title
Endoscopic Retrograde Cholangiopancreatography
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 15 years or older
- Underwent Endoscopic Retrograde Cholangiopancreatography (ERCP) between January 1, 2000 and December 31, 2025
- Included in Methodist Dallas Medical Center's registry
You will not qualify if you...
- Patients younger than 15 years
- Cannulation performed via a surgical anastomosis
- Cannulation not attempted due to gastric outlet obstruction
- Main papilla not found during procedure
- Minor papilla not found during procedure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 25 years
Participants undergo Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures as part of routine clinical care.
Visits occur as participants undergo ERCP procedures between January 1, 2000 and December 31, 2025
Duration - Up to 25 years
Participants who undergo routine care are observed through data collection in the registry over time.
Trial Site Locations
Total: 1 location
1
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texas, United States, 75203
Actively Recruiting
Research Team
C
Crystee Cooper, DHEd
K
Kavya Mankulangara
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here